URCH launches pharma pricing system guide for MENA region

28 May 2006

London, UK-based URCH Publishing has published of a series of briefings on the pricing and reimbursement systems in nine major MENA (Middle East and North Africa) markets. The reports cover Algeria, Egypt, Israel, Jordan, Lebanon, Morocco, Saudi Arabia, Tunisia and the United Arab Emirates.

This set of publications will benefit executives by concisely explaining the key elements of pricing and reimbursement regulation, offering insight into the latest policies and political environment and increasing knowledge of the methods by which governments influence and control the pharmaceutical industry, says URCH.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight